Chemotherapeutic agents have, to date, not been too successful as adjuvants to surgical or radiotherapeutic treatment. Partial responses have been noted with single agent methotrexate, adriamycin, 5-FU, cytoxan, mitomycin C and cisplatin.
Intravesical chemotherapy has been shown to reduce recurrences